Cefuroxime Axetil | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Cefuroxime Axetil
USP

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Cefuroxime Axetil

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

59 API Suppliers, 39 USDMF, 21 CEP/COS, 10 EU WC, 22 KDMF, 4 NDC API, 16 Listed Suppliers, $ API Reference Price

59 API Suppliers
39 USDMF
21 CEP/COS
10 EU WC
22 KDMF
4 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

229 FDF Dossiers, 34 FDA Orange Book, 112 Europe, 7 Canada, 8 South Africa, 68 Listed Dossiers

229 FDF Dossiers
34 FDA Orange Book
112 Europe
7 Canada
8 South Africa
68 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - EQ 125MG BASE/5ML, FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML

TABLET;ORAL - EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - EQ 125MG BASE/5ML
FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML

RELATED EXCIPIENT COMPANIES

3 Evonik, 4 Rochem International Inc, 20 SPI Pharma, 9 DKSH, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 2 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 19 BASF, 2 Clariant, 12 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 30 Direct Compression, 30 Thickeners and Stabilizers, 30 Controlled & Modified Release, 26 Lubricants & Glidants, 24 Solubilizers, 23 Taste Masking, 21 Disintegrants & Superdisintegrants, 20 Topical, 19 Granulation, 19 Chewable & Orodispersible Aids, 16 Parenteral, 16 Film Formers & Plasticizers, 16 Co-Processed Excipients, 10 Emulsifying Agents, 9 Rheology Modifiers, 7 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Coloring Agents

61 Fillers, Diluents & Binders
56 Coating Systems & Additives
30 Direct Compression
30 Thickeners and Stabilizers
30 Controlled & Modified Release
26 Lubricants & Glidants
24 Solubilizers
23 Taste Masking
21 Disintegrants & Superdisintegrants
20 Topical
19 Granulation
19 Chewable & Orodispersible Aids
16 Parenteral
16 Film Formers & Plasticizers
16 Co-Processed Excipients
10 Emulsifying Agents
9 Rheology Modifiers
7 API Stability Enhancers
5 Empty Capsules
5 Surfactant & Foaming Agents
4 Vegetarian Capsules
4 Coloring Agents

DIGITAL CONTENT

11 News #PharmaBuzz

11 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 112 Regulatory FDF Prices

1 US Medicaid Prescriptions
112 Regulatory FDF Prices

MARKET PLACE

25 APIs, 30 FDF Dossiers

25 APIs
30 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 Health Canada Patents

9 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 3 USP, 5 Others

1 EDQM
3 USP
5 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 136 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

3 All

01 11098220

02 11098231

03 11098253

filter Description Reset all filters

3 All

01 1Cefuroxime Axetil (350 mg)

02 1Cefuroxime Axetil Delta-3-Isomers (10 mg) ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate)

03 1Cefuroxime Axetil E-isomers (15 mg) (1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(E)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate)

filter CAS Number Reset all filters

3 All

01 164544-07-6

02 197232-96-7

03 1N/A

Product Main Page

01

USP

Immuno-Oncology 360

Not Confirmed

USP

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Cefuroxime Axetil E-isomers (15 mg) (1RS,6R,7...

CAS Number : 97232-96-7

Quantity Per Vial :

Price ($) : 715

Catalog Number : 1098253

Current Lot : F034U0

Previous Lot :

NDC Code :

Product Web Link

Digital Content

02

USP

Immuno-Oncology 360

Not Confirmed

USP

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Cefuroxime Axetil Delta-3-Isomers (10 mg) ((1...

CAS Number : N/A

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1098231

Current Lot : R04630

Previous Lot : J0K016 (30-SEP-2017)

NDC Code :

Product Web Link

Digital Content

03

USP

Immuno-Oncology 360

Not Confirmed

USP

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Cefuroxime Axetil (350 mg)

CAS Number : 64544-07-6

Quantity Per Vial :

Price ($) : 230

Catalog Number : 1098220

Current Lot : R011M0

Previous Lot : H0K039 (30-SEP-2015)

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!